Add-on Acquisition • Life Science

Vertice Pharma Acquires VistaPharm

On November 17, 2015, Vertice Pharma acquired life science company VistaPharm

Acquisition Context

This is Vertice Pharma’s 1st transaction in the Life Science sector.
This is Vertice Pharma’s 1st transaction in the United States.
This is Vertice Pharma’s 1st transaction in New Jersey.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	November 17, 2015
Target	VistaPharm
Sector	Life Science
Buyer(s)	Vertice Pharma
Deal Type	Add-on Acquisition

Target Company

VistaPharm

New Providence, New Jersey, United States

VistaPharm, Inc. is a specialized generics manufacturer of liquid and unit dosage pain medications for the hospital market, retail pharmacy and outpatient clinics.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Vertice Pharma

New Providence, New Jersey, United States

Category	Company
Sector	Life Science

DESCRIPTION

Vertice Pharma is a specialty pharmaceuticals company focused on improving patients’ health. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma is based in New Providence, New Jersey.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: New Jersey	1 of 1
Country: United States	1 of 1
Year: 2015	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - New Jersey M&A - United States M&A - 2015 M&A